DxUpClose
Latest round
- Series A
Last raised
- Aug 2012
Total raised
- $1M
Investors
- 1
About DxUpClose
DxUpClose, Inc. is engaged in developing a point-of-care bacterial diagnostic that perform an antibiotic sensitivity test in sixty minutes. The product is designed to screen for specific bacteria, regardless if the sample has the targeted bacteria, it will count the bacteria that are there and perform antibiotic sensitivity tests - all within sixty minutes.
Who invested in DxUpClose
1 investor across 1 round
See all investors in DxUpClose
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 15, 2012
Amount
$1M
Investors
Questions about DxUpClose
Who invested in DxUpClose?
DxUpClose has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DxUpClose raised?
DxUpClose has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DxUpClose last raise money?
DxUpClose's most recent round on record is a Series A, in Aug 2012.
What does DxUpClose do?
DxUpClose is a biotechnology company.
Where is DxUpClose headquartered?
DxUpClose is headquartered in Dallas, US.
Which VCs invest in companies like DxUpClose?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DxUpClose's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DxUpClose? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.